1.Kessler, RC, Bromet, EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013;24:119–138.
2.Bromet, E, Andrade, LH, Hwang, I, Sampson, NA, Alonso, J, de Girolamo, G, et al.Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 2011;9(90):1-16.
3.Otte, C, Gold, SM, Penninx, BW, Pariante, CM, Etkin, A, Fava, M, et al.Major depressive disorder. Nat Rev Dis Prim. 2016;15(2):16065.
4.Rock, PL, Roiser, JP, Riedel, WJ, Blackwell, AD. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2014;44:2029–2040.
5.Wagner, S, Müller, C, Helmreich, I, Huss, M, Tadić, A. A meta-analysis of cognitive functions in children and adolescents with major depressive disorder. Eur Child Adolesc Psychiatry. 2015;24:5–19.
6.Lee, RSC, Hermens, DF, Porter, MA, Redoblado-hodge, MA. A meta-analysis of cognitive deficits in first-episode major depressive disorder. J Affect Disord. 2012;140:113–124.
7.Snyder, HR. Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review. Psychol Bull. 2013;139(1):81–132.
8.Roiser, JP, Sahakian, BJ. Hot and cold cognition in depression. CNS Spectr. 2013;18:139–149.
9.Lemoult, J, Gotlib, IH. Depression: a cognitive perspective. Clin Psychol Rev. 2019;69:51–66.
10.Hasselbalch, BJ, Knorr, U, Kessing, LV. Cognitive impairment in the remitted state of unipolar depressive disorder: a systematic review. J Affect Disord. 2011;134:20–31.
11.Bora, E, Harrison, BJ, Yu, M. Cognitive impairment in euthymic major depressive disorder: a meta-analysis. Psychol Med. 2013;43:2017–2026.
12.Semkovska, M, Quinlivan, L, Grady, TO, Johnson, R, Collins, A, Connor, JO, et al.Cognitive function following a major depressive episode: a systematic review and meta-analysis. Lancet Psychiatry. 2019;6:851–861.
13.Cullen, B, Smith, DJ, Deary, IJ, Pell, JP, Keyes, KM, Evans, JJ. Understanding cognitive impairment in mood disorders: mediation analyses in the UK Biobank cohort. Br J Psychiatry. 2019;215(5):1–8.
14.Cullen, B, Nicholl, BI, Mackay, DF, Martin, D, Ul-haq, Z, McIntosh, A, et al.Cognitive function and lifetime features of depression and bipolar disorder in a large population sample: cross-sectional study of 143,828 UK Biobank participants. Eur Psychiatry. 2015;30:950–958.
15.Lyall, DM, Cullen, B, Allerhand, M, Smith, DJ, Mackay, D, Evans, J, et al.Cognitive test scores in UK Biobank: data reduction in 480,416 participants and longitudinal stability in 20,346 participants. PLoS One. 2016;11(4):1–10.
16.Fawns-Ritchie, C, Deary, IJ. Reliability and validity of the UK Biobank cognitive tests. medRxiv [preprint]. 2019;1–26.
17.Kessler, RC, Andrews, G, Mroczek, D, Ustün, TB, Wittchen, HU. The World Health Organization Composite International Diagnostic Interview Short-Form (CIDI-SF). Int J Methods Psychiatr Res. 1998;7(4):171–185.
18.Burcusa, SL, Iacono, WG. Risk for recurrence in depression. Clin Psychol Rev. 2007;27:959–985.
19.McClintock, SM, Husain, MM, Greer, TL, Cullum, CM. Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis. Am Psychol Assoc. 2010;24(1):9–34.
20.Ahern, E, Semkovska, M. Cognitive functioning in the first-episode of major depressive disorder: a systematic review and meta-analysis. Neuropsychology. 2017;31(1):52–72.
21.Schweizer, S, Kievit, RA, Emery, T, Cam-CAN, Henson, RN. Symptoms of depression in a large healthy population cohort are related to subjective memory complaints and memory performance in negative contexts. Psychol Med. 2018;48:104–114.
22.Evans, VC, Iverson, GL, Yatham, LN, Lam, RW. The relationship between neurocognitive and psychosocial functioning in major depressive disorder: a systematic review. J Clin Psychiatry. 2014;75(12):1359–1370.
23.Cambridge, OR, Knight, MJ, Mills, N, Baune, BT. The clinical relationship between cognitive impairment and psychosocial functioning in major depressive disorder: a systematic review. Psychiatry Res. 2018;269:157–171.
24.Knight, MJ, Air, T, Baune, BT. The role of cognitive impairment in psychosocial functioning in remitted depression. J Affect Disord. 2018;235:129–134.
25.McIntyre, RS, Cha, DS, Soczynska, JK, Woldeyohannes, HO, Gallaugher, LA, Kudlow, P, et al.Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates and treatment interventions. Depress Anxiety. 2013;30:515–527.
26.Kessler, RC, Akiskal, HS, Ames, M, Birnbaum, H, Greenberg, P, Hirschfeld, RMA, et al.The prevalence and effects of mood disorders on work performance in a nationally representative sample of US workers. Am J Psychiatry. 2006;163(9):1561–1568.
27.Chakrabarty, T, Lam, RW. Cognitive dysfunction in major depressive disorder: assessment, impact and management. Neuropsychology. 2016;31(1):52–72.
28.Keefe, RSE, McClintock, SM, Roth, RM, Doraiswamy, PM, Tiger, S, Madhoo, M. Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review. J Affect Disord. 2014;75(8):864–876.
29.Rosenblat, JD, Kakar, R, McIntyre, RS. The cognitive effects of antidepressants in major depressive disorder: a systematic review and meta-analysis of randomized clinical trials. Int J Neuropsychopharmacol. 2015;19(2):1–13.
30.McIntyre, RS, FLorea, I, Tonnoir, B, Loft, H, Lam, RW, Cronquist Christensen, M. Efficacy of vortioxetine on cognitive functioning in patient with major depressive disorder. J Clin Psychiatry. 2017;78(1):115–121.
31.Baune, BT, Brignone, M, Larsen, KG. A network meta-Analysis comparing effects of various antidepressant classes on the digit symbol substitution test (DSST) as a measure of cognitive dysfunction in patients with major depressive disorder. Int J Neuropsychopharmacol. 2018;21(2):97–107.
32.Nierenberg, AA, Loft, H, Olsen, CK. Treatment effects on residual cognitive symptoms among partially or fully remitted patients with major depressive disorder: a randomized, double-blinded, exploratory study with vortioxetine. J Affect Disord. 2019;250:35–42.
33.Nagane, A, Baba, H, Nakano, Y, Maeshima, H, Hukatsu, M, Ozawa, K, et al.Comparative study of cognitive impairment between medicated and medication-free patients with remitted major depression: class-specific influence by tricyclic antidepressants and newer antidepressants. Psychiatry Res. 2014;218:101–105.
34.Lee, Y, Back, JH, Kim, J, Kim, S, Na, DL, Cheong, H-K, et al.Systematic review of health behavioral risks and cognitive health in older adults. Int Psychogeriatr. 2010;22(2):174–187.
35.Gardener, H, Wright, CB, Rundek, T, Sacco, RL. Brain health and shared risk factors for dementia and stroke. Nat Rev Neurol. 2015;11:651–657.
36.Allen, N, Sudlow, C, Downey, P, Peakman, T, Danesh, J, Elliott, P, et al.UK Biobank: current status and what it means for epidemiology. Heal Policy Technol. 2012;1:123–126.
37.Davis, KAS, JR, C, Adams, M, Allen, N, Breen, G, Cullen, B, et al.Mental health in UK Biobank revised—development, implementation and results from an online questionnaire completed by 157,366 participants. BJPsych Open. 2019;4(3):1–20.
38.Clarke, T-K, Adams, MJ, Davies, G, Howard, DM, Hall, LS, Padmanabhan, S, et al.Genome-wide association study of alcohol consumption and genetic overlap with other health-related traits in UK Biobank (N = 112 117). Mol Psychiatry. 2017;22:1376–1384.
39.Wain, LV, Shrine, N, Miller, S, Jackson, VE, Ntalla, I, Artigas, MS, et al.Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank. Lancet Respir Med. 2015;3:769–781.
40.Johnson, W, Te Nijenhuis, J, Bouchard, TJ. Still just 1 g: consistent results from five test batteries. Intelligence. 2008;36:81–95.
41.Kaser, M, Zaman, R, Sahakian, BJ. Cognition as a treatment target in depression. Psychol Med. 2017;47:987–989.
42.Solé, B, Jiménez, E, Martinez-Aran, A, Vieta, E. Cognition as a target in major depression: new developments. Eur Neuropsychopharmacol. 2015;25:231–247.
43.Bortolato, B, Miskowiak, KW, Köhler, CA, Maes, M, Fernandes, BS, Berk, M, et al.Cognitive remission: a novel objective for the treatment of major depression? BMC Med. 2016;14:9.